Amgen | AMGN - الدين

سعر السهم
340.00
التغيير اليومي
-2.57 -0.75%
شهريا
-9.81%
سنويا
21.32%
Q2 التوقعات
337.47




الدين تغيير تاريخ
AbbVie USD 1000K 70.48B 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Exelixis USD 176.46M 3.38M 2025-09
Genmab DKK 148M 5M 2025-06
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
J&J USD 45.8B 4.97B 2025-09
Merck USD 41.37B 5.97B 2025-09
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Novartis USD 32.02B 615M 2025-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09